Vascular effects of estrogens: Arterial protection versus venous thrombotic risk

Margarita P. Bracamonte, Virginia M. Miller

Research output: Contribution to journalReview articlepeer-review

38 Scopus citations


Mechanisms by which estrogen reduces the risk of arterial disease, while simultaneously increasing the risk of venous thrombosis in postmenopausal women, are not clearly understood. In addition to providing beneficial arterial effects on the lipid profile, estrogen both increases production of nitric oxide and decreases production of endothelin-1 from arterial endothelium, decreases intracellular calcium in arterial smooth muscle and might favor fibrinolysis. All of these effects could act in concert to protect against development of arterial occlusive disease. However, comparable effects on venous endothelium and smooth muscle have not been studied systematically, and although blood elements such as platelets and leukocytes contain estrogen receptors, much remains to be learned about the effect that dose and duration of estrogen-treatment might have upon these cells. An integrative approach to understanding the actions of estrogen on the venous system and the interaction of blood elements with the vascular wall is necessary before new therapeutic interventions will provide arterial protection with no risk of venous thrombosis.

Original languageEnglish (US)
Pages (from-to)204-209
Number of pages6
JournalTrends in Endocrinology and Metabolism
Issue number5
StatePublished - 2001

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Vascular effects of estrogens: Arterial protection versus venous thrombotic risk'. Together they form a unique fingerprint.

Cite this